Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Compliance 360° Part 4: How To Better Manage Your Quality Data

Executive Summary

This is Compliance 360°, a podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this fourth installment, former FDA investigations branch director Ricki Chase explains how your firm can better manage its quality data.

When it comes to convincing company management that activities surrounding the collection and use of quality data is of the utmost importance, sometimes it's all about showing top brass the money.

"If the regulatory and [FDA] expectations alone do not convince you or your leadership that quality data are critical to the success and safety of your device, then perhaps the money will," Ricki Chase says in the fourth installment of Compliance 360°, a podcast series from Medtech Insight on US FDA compliance and enforcement issues.

"Studies have found that adopting quality practices such as those by the top quality performers in industry can reduce your manufacturing costs by 20% to 30%, and your profits may increase by as much as 3% to 4%," she said. "Additionally, quality improvement leads to greater customer satisfaction and a competitive advantage.

"And after all, who wouldn’t like more profitability?"

In the podcast, Chase – a former FDA investigations branch director – explains how your firm can better manage its quality data.

Chase is compliance practice director for Lachman Consultant Services, a firm she joined in June 2016 after spending 16 years at FDA, where she was also an investigator, medical device specialist and supervisory investigator.

Listen to the podcast via the player below:

 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104501

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel